Gapping up
In reaction to earnings/guidance:
- BB +7.8% DRI +4.2% FUL +2.7% ACN +1.6%
Other news:
- AMHC +52.7% (receives shareholder approval for combination with Jasper Therapeutics)
- TCI +10.6% (Brixton Capital and The Shidler Group seek to acquire 100% of the outstanding capital stock of Transcontinental Realty Investors for $44.40/share in cash)
- BEAM +2.6% (reports preclinical data highlighting optimized LNP delivery approaches)
- ARCT +2.4% (CEO met with President of Vietnam and CEO of Vingroup to discuss ongoing collaboration for supply of COVID-19 vaccines)
- GENI +2.1% (stock offering)
- EGLX +2.1% (provided an update on the development of its social network for gamers Project GG)
- ARD +2% (declares special cash dividend of $1.25/sh)
- ICLR +2% (secures R&D funding to enhance its data solutions and decentralized clinical trial technology)
- LATN +1.9% (Union Acquisition Corp. II announces shareholder approval of business combination with Procaps Group)
- EVGO +1.9% (announced the expansion of EVgo Fleet Charging Solutions with a new suite of services to support fleets as they electrify their vehicles)
- SLDB +1.7% (reports 1.5-year data from patients in the ongoing IGNITE DMD Phase I/II clinical trial of SGT-001; Patient reported outcomes showed sustained improvements)
- WLTW +1.5% (increases share buyback authorization by $4 bln)
- ABCL +1.5% (enters into collaboration and license agreement with Everest Medicines)
- CHPT +1.4% (WEX and CHPT announce plans to expand relationship to ease integration of EVs into corporate fleets)
- OPEN +1.4% (Access Technology Ventures' increases ownership by $300 mln to become the largest shareholder)
- YUMC +1.1% (outlines strategy; accelerating store network expansion to reach 20000 stores; plans to accelerate the expansion of Lavazza cafés in China)
- BNTX +1.1% (BioNTech and Pfizer receive first EUA for COVID-19 vaccine booster)
Analyst comments:
- PLUG +4.6% (upgraded to Overweight from Neutral at Piper Sandler)
- ERJ +4% (upgraded to Buy from Neutral at Goldman)
- DADA +3.5% (upgraded to Overweight from Equal-Weight at Morgan Stanley)
- ARGX +3% (upgraded to Buy from Neutral at Redburn)
- ROKU +3% (upgraded to Buy from Neutral at Guggenheim)
- LBTYA +2.5% (upgraded to Buy from Hold at Jefferies)
- VTR +1.4% (upgraded to Strong Buy from Outperform at Raymond James)